NCT03448458View on ClinicalTrials.gov

Gallium Ga 68-DOTATATE PET/CT in Diagnosing Patients With Metastatic Castration Resistant Prostate Cancer

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 22, 2018

Primary Completion Date

February 6, 2023

Study Completion Date

February 6, 2023

Conditions

Castration-Resistant Prostate CarcinomaMetastatic Prostate CarcinomaStage IV Prostate Cancer AJCC v7

Interventions

PROCEDURE

CT (Computed Tomography)

Undergo PET/CT

DRUG

Gallium Ga 68-DOTATATE

Given IV

PROCEDURE

Positron Emission Tomography

Undergo PET/CT

Trial Locations (1)

30322

Emory University Hospital/Winship Cancer Institute, Atlanta

All Listed Sponsors

lead

Emory University

OTHER

NCT03448458 - Gallium Ga 68-DOTATATE PET/CT in Diagnosing Patients With Metastatic Castration Resistant Prostate Cancer | Biotech Hunter | Biotech Hunter